Native LED technology will enable hospitals to save money and free up beds in maternity wards.
Researchers have retraced the pathogen’s route as it spread from the state of Pará by analyzing tissue samples from dead monkeys. Their findings are published in Scientific Reports.
Scientists at the Center for Research on Inflammatory Diseases (CRID) show why pediatric patients with sepsis suffer from more inflammation and organ injury than adults. New treatment strategies may be tested.
In a study with mice, a gene therapy developed in Brazil kills cancer cells and avoids adverse side effects when combined with chemotherapy.
Studies show that in addition to skeletal muscle, the heart, liver and central nervous system are affected. The systemic action of proinflammatory cytokines explains only part of the phenomenon.
Ranavirus is linked to amphibian decline or extinction in other parts of the world, but in Brazil, it has been reported only in captive animals.
With support from FAPESP’s program aimed at small businesses, Brazilian entrepreneurs have created the Eyer, a device coupled to a smartphone that detects retinopathy at a far lower cost than conventional equipment.
In experiments with mice, Brazilian scientists demonstrated that a moderate training protocol reduced liver fat and made the organ more sensitive to insulin, even before loss of body weight occurred.
Article signed by researchers affiliated with institutions in the US, UK, Ghana and Brazil highlights recent progress in diagnosis and treatment but warns that more screening of newborns is needed.
The nuclear medicine technique, combined with other kinds of analyses, more precisely distinguishes Alzheimer’s from other neurodegenerative diseases; the test has yet to be approved for routine use in clinical practice.
Study shows that brain activity related to auditory perception parallels heart rate, offering new perspectives for the treatment of attention and communication disorders.
Implantable devices which could improve the quality of patients’ lives – Australian-made and still under tests – were presented to the congress of BRAINN, a FAPESP-funded Research, Innovation and Dissemination Center.
Brazilian tech startup Bright Photomedicine is also testing the anti-inflammatory and neurological action of photobiomodulation.
Brazilian researchers arrived at this conclusion after conducting cardiovascular fitness tests with boys and girls aged 10-17. The results were published in Cardiology in the Young.
Study suggests that people with low levels of PDIA1 in blood plasma may be at high risk of thrombosis; this group also investigated PDIA1’s specific interactions in cancer.
Brazilian researchers combined cognitive dysfunction tests with an analysis of drug use patterns to identify patients at high risk of relapse after treatment
Device developed by Spanish researchers detects the presence of the gluten peptide most resistant to digestion in urine samples. The operation is as simple as that of a drugstore pregnancy test.
A study by Brazilian researchers in partnership with Harvard estimates the impact of five risk factors on the incidence of cancer– physical inactivity, unhealthy diet, overweight, smoking and alcohol consumption.
International research group demonstrates the involvement of singlet molecular oxygen in vasodilation, causing a sharp decline in blood pressure in severe inflammatory processes such as sepsis.
Peptide developed in Brazil is capable of binding to the blood-brain barrier that protects the central nervous system and could help create novel imaging tests to diagnose Alzheimer’s and Parkinson’s.
Violet pigment produced by microorganisms found in the environment, such as Chromobacterium violaceum, displays various biological activities.
The Center for Research in Optics and Photonics, supported by FAPESP, has developed a device for the noninvasive treatment of nonmelanoma skin cancer, the most frequent type worldwide.
A review article authored by Brazilian researchers evaluated several compounds with therapeutic potential against gastric tumors.
Novel therapy developed in Israel uses a laser-activated photosensitizing drug to attack early-stage prostate cancer, according to a presentation delivered to an international event on biophotonics supported by FAPESP.
Survey covering 163 municipalities showed that toothache, bleeding and periodontal disease affected 50.57% of respondents, a proportion considered high by specialists.
